The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Dec. 29, 2018
Applicants:
National Research Council of Canada, Ottawa, CA;
The Governing Council of the University of Toronto, Toronto, CA;
Inventors:
Janelle Sauvageau, Ottawa, CA;
Andrew Cox, Ottawa, CA;
Xinyi Guo, North York, CA;
Scott Gray-Owen, Oakvill, CA;
Assignees:
NATIONAL RESEARCH COUNCIL OF CANADA, Ottawa, CA;
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO, Toronto, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 11/04 (2006.01); A61K 39/00 (2006.01); A61K 39/002 (2006.01); A61K 39/005 (2006.01); A61K 39/008 (2006.01); A61K 39/015 (2006.01); A61K 39/02 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/08 (2006.01); A61K 39/085 (2006.01); A61K 39/09 (2006.01); A61K 39/095 (2006.01); A61K 39/118 (2006.01); A61K 39/125 (2006.01); A61K 39/145 (2006.01); A61K 39/15 (2006.01); A61K 39/155 (2006.01); A61K 39/205 (2006.01); A61K 39/215 (2006.01); A61K 39/23 (2006.01); A61K 39/235 (2006.01); A61K 39/39 (2006.01); A61K 45/06 (2006.01); C07H 13/00 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
C07H 11/04 (2013.01); A61K 39/002 (2013.01); A61K 39/005 (2013.01); A61K 39/008 (2013.01); A61K 39/0011 (2013.01); A61K 39/015 (2013.01); A61K 39/0208 (2013.01); A61K 39/0225 (2013.01); A61K 39/0233 (2013.01); A61K 39/0258 (2013.01); A61K 39/0275 (2013.01); A61K 39/0283 (2013.01); A61K 39/0291 (2013.01); A61K 39/08 (2013.01); A61K 39/085 (2013.01); A61K 39/092 (2013.01); A61K 39/095 (2013.01); A61K 39/099 (2013.01); A61K 39/118 (2013.01); A61K 39/125 (2013.01); A61K 39/145 (2013.01); A61K 39/15 (2013.01); A61K 39/155 (2013.01); A61K 39/205 (2013.01); A61K 39/215 (2013.01); A61K 39/23 (2013.01); A61K 39/235 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61K 47/549 (2017.08); C07H 13/00 (2013.01);
Abstract
Heptose-1-monophosphate-7-derivatives are modifiable immunomodulators that can be used to prepare clinically active conjugate compounds. Such conjugate compounds are useful in modulating an immune response in a subject.